Compare StocksAMZN vs MRNA

Amazon.com, Inc. (AMZN) vs Moderna, Inc. (MRNA): Which Is the Better Buy in 2026?

As of 2026-08-03, AMZN is overvalued at $272, with a DCF intrinsic value of $99 and a margin of safety of -176%. MRNA is fairly valued at $55, with an intrinsic value of $67 and a margin of safety of 18%. Of the two, MRNA has the wider margin of safety.

AMZN
Amazon.com, Inc.
$271.58
VS
MRNA
Moderna, Inc.
$54.82

Rewards

AMZN
  • Each dollar of retained earnings has created $5.34 of earning power — management is an exceptional capital allocator.
  • Trailing P/E of 21.8x is 46% below the historical average of 40.6x — potentially undervalued relative to its own history.
  • Altman Z-Score of 5.30 indicates very low bankruptcy risk — the company is firmly in the safe zone.
MRNA

    Risks

    AMZN
    • FCF yield of 0.3% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
    • 9 insider sales totaling $20.3M with no purchases in the past 3 months — insiders are reducing their exposure.
    MRNA
    • ROIC has declined by 67.4 percentage points over the past 4 years, which may signal competitive erosion.
    • Gross margin of -66.0% is low, suggesting a competitive or commodity-like market with limited pricing power.
    • Moderna, Inc. scores only 17/100 on the Economic Moat Score, suggesting limited durable competitive advantages.

    Key Valuation Metrics

    Learn more →
    AMZN
    MRNA
    Valuation
    $7.70B
    Free Cash Flow
    $299.25M
    0.26%
    FCF Yield
    1.38%
    21.83
    Trailing P/E
    N/A
    26.44
    Forward P/E
    -11.40
    Quality & Moat
    10.44%
    ROIC
    -122.02%
    30.56%
    ROE
    -39.00%
    50.77%
    Gross Margin
    -66.02%
    1.46
    PEG Ratio
    N/A
    Balance Sheet Safety
    0.23
    Net Debt / Equity
    Net cash
    N/A
    Interest Coverage
    N/A
    0.76
    Net Debt / EBITDA
    N/A
    0.00%
    Dividend Yield
    0.00%
    AMZN: 4Ties: 1MRNA: 4
    AMZNMRNA

    Historical Fundamentals

    Learn more →
    AMZN

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    MRNA

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    AMZN
    $9.66
    created per $1 retained over 3 years
    Exceptional Value Creator
    Σ Retained
    $167.34B
    Δ Market Cap
    +$1.62T
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    MRNA
    N/A
    Net losses over 3 years — test not applicable
    Company had negative cumulative retained earnings
    Σ Retained
    $-11.10B
    Δ Market Cap
    $-57.53B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    AMZN
    175.5% Overvalued
    Price is 175.5% above estimated fair value
    Current Price: $271.58
    Fair Value: $98.58
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    MRNA
    18.2% Margin of Safety
    Price is 18.2% below estimated fair value
    Current Price: $54.82
    Fair Value: $66.99
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    AMZN

    What growth rate is the market pricing in at $272?

    +16.9%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +50.5%

    The market implies +16.9% Owner Earnings growth, below historical trends — potential opportunity.

    Standard FCF implies a more demanding +50.5%, reflecting heavy growth investment expected to generate future returns.

    MRNA

    What growth rate is the market pricing in at $55?

    +22.7%
    Market-Implied FCF Growth Rate

    Market pricing in significantly higher growth than history — aggressive.

    Economic Moat Score

    Learn more →
    AMZN
    51/100
    Narrow Moat
    70+ Wide · 40-69 Narrow · <40 None

    Narrow moat with revenue predictability as the key competitive advantage. Improving margin stability would strengthen the moat.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
    MRNA
    17/100
    No Moat
    70+ Wide · 40-69 Narrow · <40 None

    No durable competitive advantage detected. The business shows limited evidence of pricing power, consistent returns, or capital efficiency.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

    Forensic Accounting

    Learn more →
    AMZN
    -2.58
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    MRNA

    Insufficient data for Beneish M-Score calculation (requires 2+ years).

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    AMZN
    Insiders 8.9%Institutions 67.8%Retail & Other 23.3%
    No. of Institutional Holders7,773
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    MRNA
    Insiders 7.3%Institutions 78.4%Retail & Other 14.3%
    No. of Institutional Holders1,066
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    AMZN
    0
    Buys (3M)
    0
    Buys (12M)
    No open market insider purchases found.
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    MRNA
    0
    Buys (3M)
    0
    Buys (12M)
    SAGAN PAUL L
    Director
    $1.00M
    @ $31.76 · 2025-03-03
    BANCEL STEPHANE J
    Chief Executive Officer
    $5.00M
    @ $31.22 · 2025-03-03
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    AMZN
    9
    Sells (3M)
    45
    Sells (12M)
    Total value (12M): $113.10M
    HERRINGTON DOUGLAS J
    Officer
    $239,770
    @ $239.77 · 2026-07-01
    HERRINGTON DOUGLAS J
    Officer
    $266,190
    @ $266.19 · 2026-06-01
    ZAPOLSKY DAVID A.
    Officer
    $4.12M
    @ $266.49 · 2026-05-22
    GARMAN MATTHEW S
    Officer
    $4.07M
    @ $263.40 · 2026-05-21
    HERRINGTON DOUGLAS J
    Officer
    $1.67M
    @ $262.39 · 2026-05-21
    JASSY ANDREW R.
    Chief Executive Officer
    $5.27M
    @ $263.42 · 2026-05-21
    REYNOLDS SHELLEY L
    Officer
    $620,003
    @ $262.38 · 2026-05-21
    GARMAN MATTHEW S
    Officer
    $3.01M
    @ $262.66 · 2026-05-15
    HERRINGTON DOUGLAS J
    Officer
    $982,602
    @ $262.59 · 2026-05-15
    HERRINGTON DOUGLAS J
    Officer
    $7.83M
    @ $274.67 · 2026-05-04
    JASSY ANDREW R.
    Chief Executive Officer
    $8.62M
    @ $275.00 · 2026-05-04
    RUBINSTEIN JONATHAN J
    Director
    $1.01M
    @ $273.02 · 2026-04-30
    RUBINSTEIN JONATHAN J
    Director
    $1.00M
    @ $260.00 · 2026-04-24
    JASSY ANDREW R.
    Chief Executive Officer
    $7.91M
    @ $255.00 · 2026-04-17
    HERRINGTON DOUGLAS J
    Officer
    $5.02M
    @ $245.00 · 2026-04-14
    HERRINGTON DOUGLAS J
    Officer
    $210,500
    @ $210.50 · 2026-04-01
    HERRINGTON DOUGLAS J
    Officer
    $204,250
    @ $204.25 · 2026-03-02
    ZAPOLSKY DAVID A.
    Officer
    $3.65M
    @ $205.40 · 2026-02-24
    GARMAN MATTHEW S
    Officer
    $3.64M
    @ $205.22 · 2026-02-23
    HERRINGTON DOUGLAS J
    Officer
    $1.41M
    @ $205.82 · 2026-02-23
    JASSY ANDREW R.
    Chief Executive Officer
    $4.08M
    @ $205.18 · 2026-02-23
    REYNOLDS SHELLEY L
    Officer
    $554,892
    @ $205.90 · 2026-02-23
    HERRINGTON DOUGLAS J
    Officer
    $948,990
    @ $198.37 · 2026-02-17
    ALEXANDER KEITH BRIAN
    Director
    $183,492
    @ $203.88 · 2026-02-12
    HERRINGTON DOUGLAS J
    Officer
    $208,000
    @ $208.00 · 2026-02-11
    HERRINGTON DOUGLAS J
    Officer
    $583,050
    @ $233.22 · 2025-12-01
    ZAPOLSKY DAVID A.
    Officer
    $4.56M
    @ $220.58 · 2025-11-24
    HERRINGTON DOUGLAS J
    Officer
    $1.48M
    @ $216.40 · 2025-11-21
    GARMAN MATTHEW S
    Officer
    $3.85M
    @ $216.90 · 2025-11-21
    JASSY ANDREW R.
    Chief Executive Officer
    $4.31M
    @ $216.94 · 2025-11-21
    REYNOLDS SHELLEY L
    Officer
    $583,222
    @ $216.41 · 2025-11-21
    HUTTENLOCHER DANIEL P
    Director
    $280,317
    @ $226.61 · 2025-11-20
    HERRINGTON DOUGLAS J
    Officer
    $1.11M
    @ $232.71 · 2025-11-17
    ALEXANDER KEITH BRIAN
    Director
    $209,700
    @ $233.00 · 2025-11-17
    HERRINGTON DOUGLAS J
    Officer
    $6.14M
    @ $250.58 · 2025-11-03
    RUBINSTEIN JONATHAN J
    Director
    $2.04M
    @ $250.03 · 2025-10-31
    HERRINGTON DOUGLAS J
    Officer
    $542,750
    @ $217.10 · 2025-10-01
    HERRINGTON DOUGLAS J
    Officer
    $558,725
    @ $223.49 · 2025-09-02
    ZAPOLSKY DAVID A.
    Officer
    $4.60M
    @ $222.34 · 2025-08-22
    HERRINGTON DOUGLAS J
    Officer
    $1.51M
    @ $221.62 · 2025-08-21
    GARMAN MATTHEW S
    Officer
    $3.94M
    @ $221.57 · 2025-08-21
    JASSY ANDREW R.
    Chief Executive Officer
    $4.40M
    @ $221.58 · 2025-08-21
    REYNOLDS SHELLEY L
    Officer
    $601,755
    @ $221.64 · 2025-08-21
    OLSAVSKY BRIAN T.
    Chief Financial Officer
    $3.95M
    @ $222.74 · 2025-08-21
    HERRINGTON DOUGLAS J
    Officer
    $1.11M
    @ $232.32 · 2025-08-15
    HERRINGTON DOUGLAS J
    Officer
    $542,500
    @ $217.00 · 2025-08-01
    BEZOS JEFFREY P
    Officer and Director
    $954.28M
    @ $229.72 · 2025-07-24
    BEZOS JEFFREY P
    Officer and Director
    $1.51B
    @ $228.34 · 2025-07-22
    BEZOS JEFFREY P
    Officer and Director
    $166.45M
    @ $227.02 · 2025-07-15
    BEZOS JEFFREY P
    Officer and Director
    $1.51B
    @ $225.21 · 2025-07-14
    BEZOS JEFFREY P
    Officer and Director
    $108.68M
    @ $223.99 · 2025-07-09
    BEZOS JEFFREY P
    Officer and Director
    $665.86M
    @ $223.86 · 2025-07-07
    HERRINGTON DOUGLAS J
    Officer
    $550,144
    @ $220.06 · 2025-07-01
    BEZOS JEFFREY P
    Officer and Director
    $736.68M
    @ $221.56 · 2025-06-30
    HERRINGTON DOUGLAS J
    Officer
    $512,450
    @ $204.98 · 2025-06-02
    ZAPOLSKY DAVID A.
    Officer
    $4.18M
    @ $202.00 · 2025-05-22
    GARMAN MATTHEW S
    Chief Executive Officer
    $4.21M
    @ $201.30 · 2025-05-21
    HERRINGTON DOUGLAS J
    Chief Executive Officer
    $1.37M
    @ $200.77 · 2025-05-21
    JASSY ANDREW R.
    Chief Executive Officer
    $4.00M
    @ $201.30 · 2025-05-21
    REYNOLDS SHELLEY L
    Officer
    $541,129
    @ $200.79 · 2025-05-21
    OLSAVSKY BRIAN T.
    Chief Financial Officer
    $3.58M
    @ $201.57 · 2025-05-21
    HERRINGTON DOUGLAS J
    Chief Executive Officer
    $980,971
    @ $205.05 · 2025-05-15
    ALEXANDER KEITH BRIAN
    Director
    $210,680
    @ $210.68 · 2025-05-12
    HERRINGTON DOUGLAS J
    Officer
    $476,675
    @ $190.67 · 2025-05-01
    HERRINGTON DOUGLAS J
    Officer
    $469,975
    @ $187.99 · 2025-04-01
    HERRINGTON DOUGLAS J
    Chief Executive Officer
    $532,925
    @ $213.17 · 2025-03-03
    ZAPOLSKY DAVID A.
    Officer
    $5.47M
    @ $218.25 · 2025-02-24
    HERRINGTON DOUGLAS J
    Officer
    $1.36M
    @ $222.47 · 2025-02-21
    GARMAN MATTHEW S
    Officer
    $3.36M
    @ $220.69 · 2025-02-21
    JASSY ANDREW R.
    Chief Executive Officer
    $4.59M
    @ $220.65 · 2025-02-21
    REYNOLDS SHELLEY L
    Officer
    $1.97M
    @ $222.47 · 2025-02-21
    OLSAVSKY BRIAN T.
    Chief Financial Officer
    $3.26M
    @ $223.14 · 2025-02-21
    HERRINGTON DOUGLAS J
    Officer
    $1.26M
    @ $228.44 · 2025-02-18
    HERRINGTON DOUGLAS J
    Officer
    $6.33M
    @ $230.27 · 2025-02-12
    RUBINSTEIN JONATHAN J
    Director
    $1.00M
    @ $229.85 · 2024-12-09
    RUBINSTEIN JONATHAN J
    Director
    $1.00M
    @ $219.85 · 2024-12-04
    HERRINGTON DOUGLAS J
    Officer
    $735,000
    @ $210.00 · 2024-12-02
    GARMAN MATTHEW S
    Chief Executive Officer
    $3.05M
    @ $200.19 · 2024-11-21
    HERRINGTON DOUGLAS J
    Officer
    $1.22M
    @ $200.19 · 2024-11-21
    JASSY ANDREW R.
    Chief Executive Officer
    $4.16M
    @ $200.17 · 2024-11-21
    REYNOLDS SHELLEY L
    Officer
    $759,090
    @ $200.23 · 2024-11-21
    ZAPOLSKY DAVID A.
    Officer
    $2.34M
    @ $200.23 · 2024-11-21
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    MRNA
    4
    Sells (3M)
    8
    Sells (12M)
    Total value (12M): $17.92M
    HOGE STEPHEN
    President
    $3.61M
    @ $67.60 · 2026-07-15
    HOGE STEPHEN
    President
    $2.74M
    @ $51.37 · 2026-06-15
    KLINGER SHANNON THYME
    Officer
    $173,550
    @ $50.00 · 2026-06-04
    HOGE STEPHEN
    President
    $2.58M
    @ $48.40 · 2026-05-15
    HUSSAIN SHAH ABBAS
    Director
    $264,952
    @ $46.63 · 2026-05-01
    KLINGER SHANNON THYME
    Officer
    $726,047
    @ $52.29 · 2026-03-02
    HOGE STEPHEN
    President
    $7.81M
    @ $48.84 · 2026-02-23
    HUSSAIN SHAH ABBAS
    Director
    $13,910
    @ $27.60 · 2025-12-09
    HUSSAIN SHAH ABBAS
    Director
    $8,736
    @ $28.00 · 2025-06-11
    KLINGER SHANNON THYME
    Officer
    $23,637
    @ $44.68 · 2024-12-09
    KLINGER SHANNON THYME
    Officer
    $4,849
    @ $43.29 · 2024-12-03
    HOGE STEPHEN
    President
    $13,595
    @ $43.30 · 2024-12-03
    KLINGER SHANNON THYME
    Officer
    $60,675
    @ $42.79 · 2024-11-29
    HOGE STEPHEN
    President
    $12,452
    @ $42.79 · 2024-11-29
    MOCK JAMES M
    Chief Financial Officer
    $60,761
    @ $42.79 · 2024-11-29
    HOGE STEPHEN
    President
    $12,771
    @ $46.10 · 2024-11-11
    MOCK JAMES M
    Chief Financial Officer
    $42,986
    @ $60.12 · 2024-10-07
    KLINGER SHANNON THYME
    Officer
    $40,539
    @ $73.57 · 2024-09-09
    KLINGER SHANNON THYME
    Officer
    $8,777
    @ $76.99 · 2024-09-03
    HOGE STEPHEN
    President
    $24,483
    @ $76.99 · 2024-09-03
    KLINGER SHANNON THYME
    Officer
    $12,640
    @ $78.02 · 2024-08-29
    HOGE STEPHEN
    President
    $23,408
    @ $78.03 · 2024-08-29
    MOCK JAMES M
    Chief Financial Officer
    $12,640
    @ $78.02 · 2024-08-29
    KLINGER SHANNON THYME
    Officer
    $104,722
    @ $79.39 · 2024-08-28
    MOCK JAMES M
    Chief Financial Officer
    $104,881
    @ $79.40 · 2024-08-28
    HOGE STEPHEN
    President
    $21,363
    @ $84.11 · 2024-08-12
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    AMZN
    FearGreed
    😏Greed(65/100)

    "Market is optimistic — be cautious and ensure you have a margin of safety"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    MRNA
    FearGreed
    😨Fear(26/100)

    "Market is pessimistic — investigate whether fears are temporary or structural"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    AMZN
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Greed (65)
    MRNA
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Fear (26)
    View AMZN Full AnalysisView MRNA Full Analysis

    Frequently Asked Questions: AMZN vs MRNA

    Is Amazon.com, Inc. or Moderna, Inc. more undervalued in 2026?

    Based on our discounted cash flow model, MRNA trades at a 18.2% margin of safety (intrinsic value $67 vs. price $55), compared to AMZN's -175.5% margin of safety (intrinsic $99 vs. $272).

    Which stock has a wider economic moat, Amazon.com, Inc. or Moderna, Inc.?

    AMZN scores 51/100 (Narrow moat), while MRNA scores 17/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Is Moderna, Inc. in financial distress?

    MRNA's Altman Z-Score of 2.5 places it in the Grey zone, signaling elevated bankruptcy risk. AMZN scores 5.3 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

    Which company has better free cash flow, Amazon.com, Inc. or Moderna, Inc.?

    Moderna, Inc. (MRNA) generates a 1.4% free cash flow yield, compared to Amazon.com, Inc.'s 0.3%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

    Which stock has higher return on invested capital, Amazon.com, Inc. or Moderna, Inc.?

    AMZN earns 10.4% ROIC versus MRNA's -122.0%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.